All Industries

Direxion Closing Three ETFs

Direxion

Due to their inability to attract sufficient investment assets, the Board of Trustees of the Direxion Shares ETF Trust has decided to liquidate and close three ETFs (each, a “Fund” and collectively, the “Funds”), based on the recommendation of the Funds’ adviser, Rafferty Asset Management, LLC. The Board concluded that liquidating and closing the Funds would be in the best interest of the Funds and their shareholders. The Funds closing are as follows: The Funds will cease trading on the NYSE Arca, Inc. (“NYSE”) and will be closed to purchase by investors as of the close of regular trading on the NYSE on July 19, 2024 (the “Closing Date”). The Funds will not accept purchase orders after the Closing Date. Shareholders may sell their holdings in a Fund prior to the Closing Date and customary brokerage charges may apply to these transactions. However, from July 19, 2024 through July 30, 2024 (the “Liquidation Date”) shareholders may only be able to sell their shares to certain broker-dealers and there is no assurance that there will be a market for a Fund’s shares during this time period. From June 21, 2024 until the Liquidation Date, each Fund will be in the process of closing down and liquidating its portfolio. This process will result in a Fund increasing its cash holdings and, as a consequence, not tracking its underlying index, which is inconsistent with each Fund’s investment objective and strategy. On or about the Liquidation Date, each Fund will liquidate its assets and distribute cash pro rata to all shareholders who have not previously redeemed or sold their shares. These distributions are taxable events. In addition, these payments to shareholders may include accrued capital gains and dividends. As calculated on the Liquidation Date, each Fund’s net asset value will reflect the costs of closing the Fund. Once the distributions are complete, the Funds will terminate. About Direxion: Direxion equips investors who are driven by conviction with ETF solutions built for purpose and fine-tuned for precision. These solutions are available for a broad spectrum of investors, whether executing short-term tactical trades, or investing in thematic strategies. Direxion’s reputation is founded on developing products that precisely express market perspectives and allow investors to manage their risk exposure. Founded in 1997, the company has approximately $42.3 billion in assets under management as of March 31, 2024. For more information, please visit www.direxion.com. There is no guarantee that the Funds will achieve their investment objectives. For more information on all Direxion Shares ETFs, go to www.direxion.com, or call us at 866.301.9214. Leveraged and Inverse ETFs pursue daily leveraged investment objectives which means they are riskier than alternatives which do not use leverage. They seek daily goals and should not be expected to track the underlying index over periods longer than one day. They are not suitable for all investors and should be utilized only by sophisticated investors who understand leverage risk and who actively manage their investments. An investor should carefully consider a Fund’s investment objective, risks, charges, and expenses before investing. A Fund’s prospectus and summary prospectus contain this and other information about the Direxion Shares. To obtain a prospectus and summary prospectus call 866-476-7523 or visit our website at direxion.com. A Fund’s prospectus and summary prospectus should be read carefully before investing. Direxion Shares Risks - An investment in the ETFs involves risk, including the possible loss of principal. The ETFs are non-diversified and include risks associated with concentration that results from an ETF’s investments in a particular industry or sector, which can increase volatility. The leveraged and inverse ETF utilize derivatives, such as futures contracts and swaps which are subject to market risks that may cause their price to fluctuate over time. The leveraged and inverse ETFs do not attempt to, and should not be expected to, provide returns which are a multiple of the return of their respective index for periods other than a single day. The leveraged and inverse ETFs may also subject to leverage, correlation, daily compounding, market volatility and risks specific to an industry or sector. The non-leveraged ETFs are subject to certain risks, including imperfect index correlation and market price variance, which may decrease performance. The non-leveraged ETFs may invest in a relatively small number of issuers and, as a result, be subject to greater risk of loss with respect to its portfolio securities. The non-leveraged ETFs may experience greater fluctuation in its net asset value as compared to other investments. The non-leveraged ETFs may be appropriate for investors with a long-term investment time horizon, who primarily seek capital growth, and who are able to tolerate periods of prolonged price declines. Please read each ETF’s prospectus for a more complete description of the investment risks. There is no guarantee that an ETF will achieve its investment objective. Distributor: Foreside Fund Services, LLC. Contact Details Ditto Public Relations Danielle Black, SAE direxion@dittopr.co Company Website https://www.direxion.com/

June 21, 2024 04:39 PM Eastern Daylight Time

Copper Property CTL Pass Through Trust Releases Q1-2024 Penney Intermediate Holdings LLC Financial Statements and Master Lease Store Performance Disclosures

Copper Property CTL Pass Through Trust

Copper Property CTL Pass Through Trust (“the Trust”) has filed a Form 8-K containing the Q1-2024 consolidated financial statements of Penney Intermediate Holdings LLC for the three months ended May 4, 2024 and April 29, 2023, respectively, and related Master Lease store performance disclosures. Additional information, including the Trust’s Monthly and Quarterly Reports, as well as other filings with the Securities and Exchange Commission (“SEC”) can be accessed via the Trust’s website at www.ctltrust.net. About Copper Property CTL Pass Through Trust Copper Property CTL Pass Through Trust (the “Trust”) was established to acquire 160 retail properties and 6 warehouse distribution centers (the “Properties”) from J.C. Penney as part of its Chapter 11 plan of reorganization. The Trust’s operations consist solely of owning, leasing and selling the Properties. The Trust’s objective is to sell the Properties to third-party purchasers as promptly as practicable. The Trustee of the trust is GLAS Trust Company LLC. The Trust is externally managed by an affiliate of Hilco Real Estate LLC. The Trust is intended to be treated, for tax purposes, as a liquidating trust within the meaning of United States Treasury Regulation Section 301.7701-4(d). For more information, please visit https://www.ctltrust.net/. Forward Looking Statement This news release contains certain “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “our vision,” “plan,” “potential,” “preliminary,” “predict,” “should,” “will,” or “would” or the negative thereof or other variations thereof or comparable terminology and include, but are not limited to, the Trust’s expectations or beliefs concerning future events and stock price performance. The Trust has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Trust believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond its control. These factors, including those discussed in the Trust’s Registration Statement on Form 10 filed with the Securities and Exchange Commission (the “SEC”), may cause its actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. For a further list and description of such risks and uncertainties, please refer to the Trust’s filings with the SEC that are available at www.sec.gov. The Trust cautions you that the list of important factors included in the Trust’s SEC filings may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this news release may not in fact occur. The Trust undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. Contact Details Jessica Cummins - Investor Relations +1 847-313-4755 jcummins@hilcoglobal.com Company Website https://ctltrust.net/about/default.aspx

June 21, 2024 04:15 PM Eastern Daylight Time

ZOOMEX Leads the Charge for Gender Equality in the Crypto Industry

Zoomex

In the swiftly evolving world of cryptocurrency, ZOOMEX stands out as a pioneer dedicated to fostering a more inclusive and gender-equal industry. The global digital currency trading platform proudly announces a series of initiatives aimed at breaking down barriers and promoting gender diversity within the crypto space. These efforts are part of ZOOMEX ’s broader mission to champion diversity, equity, and inclusion (DEI) across all its operations. Commitment to Gender Equality The world of cryptocurrency has often been criticized for its gender gap, with women historically underrepresented in the industry. Recognizing this disparity, ZOOMEX is taking concrete steps to build a more balanced and inclusive environment. The exchange firmly believes that gender diversity is not just a moral imperative but also a business advantage that drives innovation and growth. “At ZOOMEX, we understand that diversity of thought and experience can propel our industry to new heights,” stated Ashley Levin, spokesperson of ZOOMEX. “We are committed to creating opportunities for women and other underrepresented groups in crypto, ensuring they have a voice and a seat at the table.” Leadership and Representation Leading by example, ZOOMEX has made significant strides in promoting women to leadership positions within the company. The exchange’s executive team is a testament to this commitment, featuring accomplished women in key roles such as Chief Financial Officer, Chief Compliance Officer, and Head of Marketing. “Having women in leadership positions is crucial for driving change,” commented Ashley Levin, spokesperson of ZOOMEX. “Our presence at the decision-making level sends a powerful message about the importance of gender diversity and serves as an inspiration for other women in the industry.” Educational Programs and Mentorship Education is a cornerstone of ZOOMEX ’s gender equality initiatives. The exchange has launched various programs aimed at educating and empowering women in cryptocurrency. These include scholarships for women pursuing blockchain-related studies, webinars featuring female industry leaders, and partnerships with educational institutions to develop inclusive curriculums. Additionally, ZOOMEX has established a mentorship program that pairs experienced female professionals with newcomers to the crypto industry. This initiative provides guidance, support, and networking opportunities, helping to bridge the gap for women entering this traditionally male-dominated field. “Our mentorship program is designed to empower the next generation of female crypto enthusiasts and professionals,” said Ashley Levin, spokesperson of ZOOMEX. “By connecting them with industry veterans, we hope to foster an inclusive community where knowledge and experience are shared freely.” Creating a Supportive Work Environment ZOOMEX recognizes that fostering gender equality requires a supportive and inclusive work environment. To this end, the exchange has implemented family-friendly policies, including flexible working hours, parental leave, and childcare support. These measures aim to create a workplace where all employees, regardless of gender, can thrive. “Creating a supportive work environment is key to retaining top talent,” said Ashley Levin, spokesperson of ZOOMEX. “Our policies are designed to ensure that our employees can balance their professional and personal lives. We want everyone, regardless of gender, to feel valued and supported at ZOOMEX.” Community Engagement and Advocacy Beyond internal initiatives, ZOOMEX is also actively engaged in promoting gender equality across the broader crypto community. The exchange regularly sponsors and participates in events that highlight the contributions of women to the industry, such as conferences, panel discussions, and hackathons. ZOOMEX is also a proud partner of several organizations dedicated to advancing women in technology and finance. By supporting these groups, the exchange aims to amplify the voices of women in crypto and advocate for policies that promote gender diversity. “Community engagement is a vital part of our mission,” explained Ashley Levin, spokesperson of ZOOMEX. “We are committed to supporting organizations and initiatives that champion gender diversity in our industry. By working together, we can create lasting change.” Global Initiatives and Impact ZOOMEX ’s commitment to gender equality is not confined to a single region; it is a global mission. The exchange is actively working to promote inclusivity in all the markets it operates in, recognizing that gender equality is a universal issue that requires a concerted effort. To further this goal, ZOOMEX has established regional diversity and inclusion committees tasked with addressing specific challenges and opportunities in different areas. These committees provide valuable insights and recommendations, ensuring that ZOOMEX ’s initiatives are culturally sensitive and impactful. “Gender equality is a global challenge, and we are dedicated to making a difference everywhere we operate,” said Ashley Levin, spokesperson of ZOOMEX. “Our regional committees play a crucial role in tailoring our initiatives to meet local needs and create meaningful impact.” Future Goals and Vision Looking ahead, ZOOMEX remains steadfast in its commitment to gender equality. The exchange has set ambitious goals to increase female representation at all levels of the company and within its user base. This includes a target of achieving 50% gender parity in its workforce by 2028, as well as increasing the number of female traders and investors on its platform. To achieve these goals, ZOOMEX will continue to invest in education, mentorship, community engagement, and policy advocacy. The exchange believes that by fostering a more gender-diverse industry, it can unlock new opportunities for growth and innovation. “We have made significant progress, but there is still much work to be done,” concluded Ashley Levin, spokesperson of ZOOMEX. “Our vision is a crypto industry where gender equality is the norm, not the exception. We are committed to leading this change and creating a more inclusive future for all.” About ZOOMEX ZOOMEX is a premier cryptocurrency exchange dedicated to providing a swift, stable and secure platform for trading cryptocurrencies. Committed to diversity, equity, and inclusion, ZOOMEX strives to create a more inclusive and equitable crypto industry for all. Zoomex Official: https://www.zoomex.com X (Twitter): https://twitter.com/ZoomexOfficial Telegram: https://t.me/zoomex_com LinkedIn: https://www.linkedin.com/company/zoomex-com Contact Person: Ashley Levin Business Mail: business@zoomex.com Contact Details ZOOMEX Ashley Levin business@zoomex.com

June 21, 2024 03:30 PM Eastern Daylight Time

Image

Aberdeen Limited Secures Landmark Victory in European Court Case

Aberdeen Limited

In a landmark decision, Aberdeen Limited, a leading fixed rate bond advisor, has emerged victorious in a high-profile legal battle that has spanned over two years. The European Court has ruled in favor of Aberdeen Limited, aﬃrming its right to operate within the European Union, marking a significant triumph for the company and the financial services sector. The case, which has garnered substantial attention due to its implications for cross-border financial operations within the EU, saw Aberdeen Limited pitted against a prominent bank. While the identity of the bank remains undisclosed, the court’s decision unequivocally supports Aberdeen’s position, ensuring their continued presence and operations in the European market. The court’s ruling also includes a substantial settlement for Aberdeen Limited. The company will receive an undisclosed sum in damages and compensation for loss of earnings, addressing the financial impact of the protracted legal proceedings and the accusations leveled against them. A spokesperson for Aberdeen Limited expressed immense satisfaction with the court’s decision. “We are delighted with the outcome,” he stated. “This ruling not only reaﬃrms our right to operate within the European Union but also vindicates our stance throughout this challenging period. While we always had confidence in our position and the eventual outcome, it is gratifying to see justice served so decisively.” The spokesperson further emphasized that this victory is a testament to Aberdeen Limited’s commitment to integrity and excellence in the financial services sector. “We have maintained our dedication to providing superior financial solutions to our clients, and this decision allows us to continue doing so without hindrance. Our clients can rest assured that Aberdeen Limited remains a steadfast and reliable partner in their financial endeavors. The ruling is expected to have far-reaching implications for the financial services industry, particularly for firms operating across multiple jurisdictions within the EU. It underscores the importance of regulatory clarity and the protection of legitimate business operations against unfounded claims. Aberdeen Limited extends its gratitude to its legal team for their unwavering dedication and expertise throughout the case. The company also thanks its clients and stakeholders for their continued support and trust during this period. With this legal hurdle now overcome, Aberdeen Limited looks forward to expanding its services and reinforcing its position as a leader in the fixed rate bond market across Europe and beyond. About Aberdeen Limited Aberdeen Limited is a premier bond advisory firm specializing in fixed rate bonds. With a commitment to excellence and a focus on delivering tailored financial solutions, Aberdeen Limited serves a diverse clientele across the globe. Contact Details Aberdeen Limited Joe Cawley joe.cawley@aberdeen-ltd.com Company Website https://aberdeen-ltd.com/

June 21, 2024 12:31 PM Eastern Daylight Time

Media Advisory: Comcast Partners with Legendary Mexican Rock Band EL TRI to Provide ASL Interpretation for the First Time at Upcoming Music in the Park Concert

Comcast California

Comcast has partnered with legendary Mexican rock band, EL TRI to provide sign language interpretation for their June 22 Music in the Park performance at Plaza de Cesar Chavez in San Jose. This marks the first time that EL TRI, whose lyrics are in Spanish, will perform with sign language interpreters to provide greater accessibility to deaf and hard-of-hearing fans. In addition to interpreting the iconic lyrics of EL TRI, interpreters from Pro Bono ASL will translate the announcers of the traditional Lucha Libre matches that Music in the Park will offer as entertainment to attendees before the concert. WHAT: • Capture historic moments of ASL interpretation at Music in the Park • Interview ASL interpreters who have worked in shows with Bad Bunny, Juanes and Elvis Crespo • Hear from Comcast about its plans to serve the Deaf and hard-of-hearing community • Lucha Libre matches will feature local wrestlers such as "El Gladiador del aire,” "El Viento" and "Rey de las pesadillas” El Cucuy, WHEN: Saturday, June 22, 2024 Doors open at 4:00 PM PT Concert starts at 8:00 PM PT Lucha Libre Matches will happen throughout the event WHO: • Alex Lora and his legendary Mexican rock band EL TRI • ASL interpreters from Pro Bono ASL - an organization that specializes in bringing immigrant, first-gen, queer, multilingual and multicultural ASL interpreters to concerts and festivals across the U.S. • Comcast representatives WHERE: • Plaza de Cesar Chavez - 1 Paseo de San Antonio, San Jose, CA 95113 About Comcast Corporation Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company that connects people to moments that matter. We are principally focused on connectivity, aggregation, and streaming with 57 million customer relationships across the United States and Europe. We deliver broadband, wireless, and video through our Xfinity, Comcast Business, and Sky brands; create, distribute, and stream leading entertainment, sports, and news through Universal Filmed Entertainment Group, Universal Studio Group, Sky Studios, the NBC and Telemundo broadcast networks, multiple cable networks, Peacock, NBCUniversal News Group, NBC Sports, Sky News, and Sky Sports; and provide memorable experiences at Universal Parks and Resorts in the United States and Asia. Visit www.comcastcorporation.com for more information. Contact Details Comcast Adriana Arvizo +1 925-200-1919 adriana_arvizo@comcast.com Company Website https://california.comcast.com/

June 21, 2024 09:00 AM Pacific Daylight Time

EuroPacific Metals Expands Drilling Program at Miguel Vacas Mine

Europacific Metals Inc

EuroPacific Metals CEO Karim Rayani joined Steve Darling from Proactive to announce the expansion of the company's drill program at the Miguel Vacas mine area. The expansion includes an additional drill hole extending down to 350 meters, targeting the high-grade zone below the fourth hole where the company previously intersected a mineralized section. This new hole will also target a section approximately 80 meters north, where the results of the first hole showed 22.8 meters grading 2.76% copper, including 9.0 meters grading 7.49% copper. Rayani explained that a decision was made to extend the drilling program by adding an undercut inclined 350-meter hole to test the "fresh" mineralization below the oxidized rich material in the same section as hole EBMV004, which revealed a wide mineralized section. The mineralized system at Miguel Vacas extends at least 2 kilometers along strike and remains open at depth. It includes an 80-meter supergene blanket containing a suite of copper carbonates, phosphates, and oxides, which gradually transitions to a sulphide assemblage primarily composed of chalcopyrite and pyrite. To date, the company has completed 10 holes at the Miguel Vacas copper deposit, totaling 1,060 meters. This expanded drilling program underscores EuroPacific Metals' commitment to thoroughly exploring and developing the Miguel Vacas mine area, aiming to uncover substantial copper resources and enhance the project's overall value. Contact Details Proactive North America +1 604-688-8158 na-editorial@proactiveinvestors.com

June 21, 2024 11:53 AM Eastern Daylight Time

Video

Fathom Nickel Secures Permits for Expanded Exploration at Gochager Lake Project

Fathom Nickel Inc

Fathom Nickel CEO Ian Fraser joined Steve Darling from Proactive to announce that the company has secured all necessary permits to advance its exploration activities at the Gochager Lake project. This project, which hosts an historic NI43-101 non-compliant open-pit resource consisting of 4.3 million tons at 0.295% nickel and 0.081% copper, will now see significant development. The newly acquired permits enable Fathom Nickel to drill up to 60 drill holes and construct an all-season, 25-person camp. Additionally, the company has received permission to use temporary "fly camps" during the summer-fall field season. These camps will support site-specific airborne geophysical anomaly follow-ups, mapping and prospecting, soil geochemistry, and site-specific geophysical surveys. The exploration permit is valid for two years, expiring in 2026. Fraser also shared that the company mobilized field crews last week to begin a soil geochemical survey. The objective is to define a soil geochemical signature associated with the Gochager Lake deposit and use this signature to locate additional similar deposits. Detailed mapping, prospecting, and soil geochemical sampling will focus on areas of conductivity identified through surface time-domain electromagnetic surveys conducted last season. Moreover, the company plans to conduct a detailed drone-MAG survey over the historic Gochager Lake deposit area, covering approximately 385 line-kilometers. These advancements mark a pivotal step in Fathom Nickel's exploration strategy, underscoring the company's commitment to expanding its resource base and uncovering new mineral deposits at Gochager Lake. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

June 21, 2024 10:00 AM Eastern Daylight Time

Video

Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks

Benzinga

By Meg Flippin, Benzinga When it comes to screening for colorectal cancer, Mainz Biomed NV (NASDAQ: MYNZ) and Exact Sciences Corp. (NASDAQ: EXAS) have a lot in common. Both are overhauling the screening market for a cancer that kills 50,000 people each year. And both are doing it without an invasive test that requires hours of uncomfortable prep. Exact Sciences, which makes Cologuard and Mainz Biomed, which makes ColoAlert, are trailblazing with their at-home cancer screening tests. Cologuard in the U.S. and ColoAlert in Europe. Take ColoAlert for starters. It spots bleeding and non-bleeding tumors through tumor DNA analysis, offering what the company says is a better early detection than fecal occult blood tests. That’s important since almost all colorectal cancers develop from polyps that grow over time. The longer the polyps are present, the higher the risk of them becoming cancerous, which is why early screening has the potential to dramatically impact treatment and prevention. Caught early, the survival rate after five years is 90% for colorectal cancer. Exact Sciences’ Cologuard looks for colorectal neoplasia-associated DNA markers and for the presence of occult hemoglobin in human stool. It, too, says its screening technology is better at detecting colorectal cancer than blood tests. Similar But Different The companies both boast high accuracy rates and customer satisfaction. But that is where the similarities end. Exact Sciences dwarfs Mainz Biomed in size and sales, sporting a market cap of $7 billion to Mainz Biomed’s $12.6 million as of this writing. Exact Sciences stock, which trades at around $42 a share, has already had a runup, while Mainz Biomed, which is under $1.00 a share, is just starting out. That might not be forever, which could position Mainz to follow a similar trajectory to Exact Sciences and other diagnostics companies specializing in the detection of early-stage cancers. Exact Sciences launched Cologuard in 2014, becoming the first DNA test for colorectal cancer in the U.S. Since then, it has expanded into other cancers and its stock and business have taken off. Mainz has been in the market since 2018 and sales have been growing at double digits since then. Revenue for ColoAlert increased 69% year-over-year in 2023 and more growth is expected this year and beyond. ColoAlert Coming To The U.S. Mainz Biomed has already made a name for itself in Europe and is gearing up to bring ColoAlert to the U.S. ColoAlert is currently under evaluation by the Food and Drug Administration for use in the U.S. as part of its ReconAAsense clinical study of about 15,000 subjects from 150 sites across the United States. The results of the study, which is pivotal for FDA approval, are expected next year. Once approved, MYNZ says it plans to establish scalable distribution through a collaborative partner program with regional and national laboratory service providers across the country. If it does get the nod from the FDA, it could prove to be a catalyst for the company’s growth. It shouldn’t prove difficult given ColoAlert’s accuracy and ease of use. The company says ColoAlert detects 85% of colorectal cancer cases, often in the very early stages of the disease. A recent multicentric study of 566 patients simultaneously using the occult blood test, M2-PK test and ColoAlert, found ColoAlert, with a sensitivity of 85% and a specificity of 92%, was the most accurate test result among the non-invasive screening methods. The company plans to engage in further testing to validate the effectiveness of its screening over what’s already available in the market. “Combined DNA stool assay represents a reliable assay for detecting colorectal cancer, sufficient to be recommended as a supplement to colonoscopy screening,” the study researchers reported. Big Opportunity On The Horizon Then there is the market opportunity. As it stands, 37 million people in the U.S. get screened for rectal cancer each year. That could increase to 52 million per year within ten years as the population ages. In the United States there are 112 million people 50+, which is expected to increase to 157 million in the next decade. Of the U.S. population between 50 and 75, about 40% have never been screened. While the common practice is to start the screening at 50, the Food and Drug Administration says screening should start at age 45 and be conducted every three years. If that guidance is followed, it presents an even bigger opportunity for ColoAlert. All told, Mainz pegs the U.S. opportunity at $4 billion and the European market opportunity at $6 billion. Colorectal cancer is deadly but it doesn’t have to be. Companies like Exact Sciences and Mainz Biomed are turning the market on its head with their at-home screening tests. While Exact Sciences dwarfs Mainz in size, Mainz has a lot of potential, especially if it gets approval to sell its test in the U.S. With that coming down the pike, Mainz is a story worth keeping an eye on. Featured photo by National Cancer Institute on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 21, 2024 08:45 AM Eastern Daylight Time

Image

“One Of The Most Significant Developments In Rapid In Vitro Diagnostics Since Its Invention” Says Gemina Labs CEO About Company’s Revolutionary Technology

Benzinga

By Meg Flippin, Benzinga Gemina Laboratories (CNSX: GLAB), the biosensor and diagnostic company focused on rapid testing for respiratory and other pathogens that affect human health and wellness, is making waves in the diagnostics sector thanks to its cutting-edge, next-gen technology. Under the leadership of CEO Brian Firth, formerly COO of Swiss Precision Diagnostics and makers of the Clear Blue Pregnancy Test, Gemina Laboratories says it is poised to transform the landscape of rapid testing for respiratory diseases and beyond. It’s a big market opportunity, given chronic respiratory disease was the third-leading cause of death in 2019. Rapid testing for it and other pathogens can reduce the spread of life-threatening illnesses and help people get treated faster. Breakthrough In Point-Of-Care Diagnostics Gemina Labs specializes in the development of unique binding technologies for the Point-of-Care (PoC) diagnostic industry. Utilizing their proprietary chemistry, Gemina's innovations reduce production costs and improve the accuracy and the useability of diagnostic tests. The company’s "game-changing" chemistry is not only reserved for its own products. Gemina Labs is also licensing it to other producers to incorporate into their lateral flow technologies. "Our chemistry is one of the most significant developments in rapid in vitro diagnostics since its invention. It reduces production costs and improves accuracy," says Firth. Expanding Horizons And Industry Impact Gemina Labs is in growth mode, pursuing its vision to make affordable, rapid and lab-accurate PoC diagnostics available worldwide. The company’s cutting-edge technology and R&D capabilities have drawn significant attention from leading biochemists, healthcare professionals, academics and business leaders globally, including a big global diagnostics company. Gemina Labs just signed a licensing agreement with what it says is one of the leading players in the $106 billion global in vitro diagnostics market. Gemina says the agreement marks a major validation of its technology after a year of extensive scrutiny and evaluation by the diagnostics company. "This is an outstanding first for Gemina," said Firth. "We are now targeting similar licensing deals with strategic partners across the life sciences and medical device sectors to enable next-generation diagnostics with our unique suite of proprietary technologies." Financial And Commercial Implications The new partnership looks poised to have significant financial implications for both Gemina and the broader diagnostics market, thanks to Gemina’s ability to reduce the antibody requirements in lateral flow. As it stands, Gemina says the antibodies used in lateral flow cost up to $1,500 per mg. Gemina’s technology can potentially reduce that by 75%, translating into $3 billion in annual savings for the lateral flow diagnostics sector. That, says Firth, is a convincing commercial opportunity for partners. "Our diagnostic technology asset has passed rigorous testing by one of the best teams in the industry, resulting in this long-term relationship. We have previously reported how one of our technology breakthroughs saves up to 75% of antibodies used on lateral flow tests," Firth said. Future Prospects Looking ahead, Gemina Labs is strategically positioning itself for further growth through additional licensing deals and partnerships. The company’s goal is to continue expanding access to rapid, accurate diagnostics – making a positive difference in the medical, healthcare, wellness and occupational health sectors. Gemina Labs isn’t your run-of-the-mill diagnostics company. It sees itself as a transformative force with the potential to revolutionize how rapid diagnostics are developed and deployed globally. Investors and industry stakeholders may want to keep an eye on this potential rising star. Featured photo by Anastasiia Chepinska on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 21, 2024 08:45 AM Eastern Daylight Time

Image

1 ... 164 165 166 167 168 ... 3788